Introduction to Caffeine Citrate
Caffeine citrate, identified by the NDC code 25021-0601, is a pharmaceutical formulation used primarily in the treatment of apnea of prematurity, a condition where premature infants stop breathing for short periods. Here, we will delve into the market analysis and price projections for this drug.
Market Overview
The pharmaceutical market, particularly for drugs like caffeine citrate, is undergoing significant transformations driven by technological advancements, regulatory changes, and shifting patient needs.
Growth Drivers
- Increasing Demand: The demand for caffeine citrate is driven by the need for effective treatments for apnea of prematurity. Advances in neonatal care and an increase in premature births contribute to this demand[3].
- Technological Advancements: The integration of AI and digital tools in drug development and supply chain management is enhancing efficiency and reducing costs. This can lead to more stable and potentially lower prices for drugs like caffeine citrate[3].
Price Trends
Current Pricing
As of the latest data, the price for caffeine citrate (NDC 25021-0601) is as follows:
- Price per Unit: The price per milliliter (mL) of caffeine citrate solution is approximately $1.34 for a 3 mL vial[1].
Historical Pricing
- The prices for caffeine citrate have shown minor fluctuations over the past year. For instance, the price per unit has ranged from $1.34 to $1.40 per mL, indicating a relatively stable pricing trend[1].
Market Projections
Forecasted Demand
- The demand for caffeine citrate is expected to remain steady or increase slightly due to advancements in neonatal care and the growing number of premature births.
- Technological Impact: AI-driven drug development and personalized medicine trends may not directly impact caffeine citrate but could influence the broader pharmaceutical market, potentially stabilizing or reducing prices[3].
Price Projections
- Given the stable pricing trend and the absence of significant market disruptions, the price per unit of caffeine citrate is likely to remain in the range of $1.30 to $1.40 per mL over the next few years.
- Regulatory and Supply Chain Factors: Any changes in regulatory requirements or supply chain efficiencies could influence pricing. However, with the current data, no major price shifts are anticipated[1].
Competitive Landscape
Key Players
- Sagent Pharmaceuticals: One of the primary vendors for caffeine citrate, offering the drug under the NDC code 25021-0601[1].
- Hikma Pharmaceuticals USA Inc.: Another major player in the market, offering similar formulations under different NDC codes[1].
Market Competition
- The market for caffeine citrate is relatively niche but competitive, with multiple vendors offering the drug. This competition helps maintain stable prices and ensures a consistent supply[1].
Regulatory Considerations
FDA and Regulatory Compliance
- Caffeine citrate must comply with FDA regulations, which can impact pricing and availability. Any changes in regulatory requirements could affect the market dynamics[3].
Patient and Healthcare Impact
Treatment Outcomes
- Caffeine citrate is crucial for treating apnea of prematurity, significantly improving the outcomes for premature infants. The stability in pricing ensures that this life-saving treatment remains accessible[1].
Healthcare Provider Perspective
- Healthcare providers benefit from the stable pricing and reliable supply of caffeine citrate, allowing them to plan and manage patient care more effectively[3].
Conclusion
The market for caffeine citrate, identified by the NDC code 25021-0601, is characterized by stable pricing and steady demand. Technological advancements and regulatory compliance are key factors influencing this market. Here are the key takeaways:
Key Takeaways
- Stable Pricing: The price per unit of caffeine citrate is expected to remain stable in the range of $1.30 to $1.40 per mL.
- Technological Impact: AI and digital tools are enhancing efficiency but do not directly impact caffeine citrate pricing.
- Regulatory Compliance: FDA regulations are crucial and can influence market dynamics.
- Competitive Market: Multiple vendors ensure a competitive market, maintaining stable prices and a consistent supply.
FAQs
Q: What is the primary use of caffeine citrate (NDC 25021-0601)?
A: Caffeine citrate is primarily used to treat apnea of prematurity in premature infants.
Q: Who are the key vendors for caffeine citrate?
A: Key vendors include Sagent Pharmaceuticals and Hikma Pharmaceuticals USA Inc.
Q: How is the price of caffeine citrate expected to change in the future?
A: The price is expected to remain stable, ranging from $1.30 to $1.40 per mL.
Q: What factors could influence the price of caffeine citrate?
A: Regulatory changes, supply chain efficiencies, and technological advancements could influence pricing.
Q: How does the competitive landscape affect the pricing of caffeine citrate?
A: The competitive market ensures stable prices and a consistent supply of the drug.
Sources
- Drug Patent Watch - Pharmaceutical drug prices and trends for CAFFEINE[1].
- SEER Cancer - Product NDC: 25021-0826; Brand Name: Zoledronic Acid[2].
- Laboratorios Rubio - The Future of Pharma: 2025's Key Trends To Know[3].
- Drug Development - NSCLC MARKET - Global Drug Forecast & Market Analysis to 2025[4].
- SEER Cancer - 25021-0820 Methylprednisolone acetate[5].
